Analysis of human enteroids and colonoids (3D organoid models from small intestine and colon) exposed to chemotherapy agent and tyrosine kinase inhibitor (TKI) gefitinib sampled at four doses (0.1, 1, 10 and 30uM) and at three time points (24, 48 and 72h) since initial exposure

ChEBI2022-04-11 更新2026-07-12 收录

肠道类器官药物毒性

吉非替尼药效评估

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-MTAB-11221 数据链接链接失效反馈

官方服务：

资源简介：

Analysis of human enteroids and colonoids (3D organoid models from small intestine and colon) exposed to chemotherapy agent and tyrosine kinase inhibitor (TKI) gefitinib sampled at four doses (0.1, 1, 10 and 30uM) and at three time points (24, 48 and 72h) since initial exposure

创建时间：

2022-04-11

Analysis of human enteroids and colonoids (3D organoid models from small intestine and colon) exposed to chemotherapy agent and tyrosine kinase inhibitor (TKI) gefitinib sampled at four doses (0.1, 1, 10 and 30uM) and at three time points (24, 48 and 72h) since initial exposure

资源简介：

相关数据集